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Introduction: The severe inflammatory responses that occurs after traumatic spinal cord 
injury (SCI) is with great strength related to the further tissue damage. As such, developmental 
strategies have been investigated, aimed at restricting inflammation and encouraging 
regeneration of injured neural tissue. One of those encouraging strategies is administration of 
traditional medicinal plants. The current study was conducted to evaluate the neuroprotective 
effects of Boswellia serrata extract on the neuronal tissue inflammation and white blood cells 
(WBCs) responses in rats with SCI. 
Methods: Forty adult female rats were randomly assigned into 2 equal groups as experimental 
and control groups. Under general inhalation anesthesia, in both groups, SCI was created, 
at T9-10 level of the column. On the third day after the operation, an oral supplement of B. 
serrata extract was administered to the experimental group at 100 mg/kg/d. The histology of 
the site of injury and changes in the WBCs were examined in both groups at different pre-
surgical and post-surgical times. 
Results: The total population of WBCs in the current study was significantly less in the 
experimental group, compared to the control group at third and fourth weeks of the study 
which could be related to the anti-inflammatory effects of B. serrata extract. Histopathological 
evaluation of lesion sites confirmed the reduced inflammatory responses in the experimental 
group compared to the control group (P < 0.05). 
Conclusion: The decrease in the number of inflammatory cells after oral consumption of B. 
serrata extract and the histopathological results confirm the neuroprotective effects of this 
extract.
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A B S T R A C T
Introduction 
Spinal cord injury (SCI) as a worldwide form of 
neurological damage can destroy central nervous system 
of patients, result in high rates of disability and create 
considerable medical costs (1,2). Trauma is one the most 
common causes of SCI; therefore, in addition to more than 
12 000 subjects that are affected once a year in the United 
States, many more are influenced in developing countries, 
additionally (3). Devastating trauma leads to primary 
injury, by the focal destruction of neural substance and 
secondary complications that can continue to weeks, and 
are related to losing strength of blood-spinal cord barrier, 
neuronal damage, oxidative stress, neuro-inflammation, 
and ischemic abnormality (4,5). 
These problems as a detrimental cascade, can be managed 
by pharmacological intercessions, but there has been 
little success or no definite curative therapy in this regard 
(6). Alternative strategies for SCI interventions such as 
traditional herbal medicine, with many thousands years 
history, would be valuable in the prevention and treatment 
of SCI. 
For thousands of years, Boswellia species or frankincense 
has been used for medical reasons. In conventional Asian 
medicine, Boswellia species are a therapeutic element 
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applied by diseases of the nervous system; Boswellia 
species were furthermore administrated for the treatment 
of various diseases of the gastrointestinal tract, and for 
gynecological plans (7). 
Boswellia serrata and its extracts are traditionally used 
to treat different types of blood disorders, inflammatory 
health conditions, cardiac debility, and pain (8). There are 
various scientific investigations about pharmacological 
actions of B. serrata-gum resin. Gummy exudates of B. 
serrata stem bark or its great constituents, boswellic acids 
possess anti-inflammatory (9,10), anti-cancerous (11) and 
anti-ulcerous (12) roles.
Boswellia with its neuroprotective activity increases 
structural development of new nerve networks (13). It also 
impedes degenerative alternations in the hippocampus, 
which is the memory-processing region in the brain 
(14). Therefore, some studies suggest that B. serrata and 
its compounds need to be scientifically investigated in 
neurophysiology and feasibly for the future handling of 
neurodegenerative disorders (7,15). Toxicology academic 
works of B. serrata resin directed on animals showed no 
notable histopathological, genotoxic, and hematological 
changes after consumption of this resin at doses up 
to 1000 mg/kg. Furthermore, the adverse effects are 
insignificant in humans, and occasionally nausea, acid 
reflux and digestive complaints have been reported in 
some consumers (16,17).
Based on the above mentioned information, the current 
study was conducted to evaluate neuroprotective effects of 
B. serrata extract on the neuronal tissues in experimental 
SCI in rat model.
Materials and Methods
Drug preparation
Boswellia serrata was bought from Iran Darouk 
Pharmaceutical Co., Iran. After grinding of B. serrata, 
1000 g of its powder was put in a clean 10-litre flask and 
mixed with 8 L of 70% ethanol for a period of 48 hours at 
indoor temperature. The final mixture was then filtered 
and dried out using a rotary evaporator at a temperature 
below 50ºC until its volume reduced to 5% of its original 
volume (18,19). Subsequently, the residual content was 
kept at refrigerator temperature. 
Animals
Forty adult female rats (Sprague-Dawley), weighing 
approximately 250-300 g were assigned in the current 
study. The animals were arbitrarily allocated into 
experimental (n = 20) and control (n = 20) groups. All rats 
were retained under controlled states at room temperature, 
with conventional humidity and a 12 h light cycle, and 
allowed free access to food and water. 
Animal model establishment and drug treatment
All rats received premedication regimen subcutaneously 
(Xylazine 10 mg/kg, Alfasan) and after 10 minutes 
anesthetized with isoflurane (Terrel Isoflurane; PCC Inc.). 
Initially, the rats were placed on the operating room 
table and a midline dorsal area was prepared, surgically. 
A midline surgical cut was made in skin at level of T8–
T11, and the bilateral para-spinal muscles exactly were 
dissected. In two groups at T9-10 level of column, due to 
dorsal laminectomy, cord compression as a SCI was made, 
using aneurysm clip for 60 seconds (20,21).
Hind limb locomotor deficiency and tail paralysis resulted 
from SCI, confirmed the efficacy of the aneurysm clip 
compression technique. After exact control of bleeding, 
paravertebral fascia and skin were sutured in the simple 
continuous pattern (21). 
Manual expression of urinary bladders, twice daily, 
was performed at the first three days after surgery and 
additionally all rats received enrofloxacin (2.5 mg/kg; 
Enrofloxacin 10%; Amineh Gostar Co.), twice daily 
for five postoperative days, in order to avoid infection. 
Seventy-two hours later from the cord compression, 
the experimental group’s animals received 100 mg/
kg B. serrata extract (Daily for 4 weeks), by traditional 
orogastric gavage. 
Histopathological assessment
At different times post-surgery (day 3, 7, 21, and 28), after 
sacrifice of the rats, a dorsal laminectomy was performed 
at the total lumbar and thoracic vertebrae levels and 
spinal cord tissue samples were collected for microscopic 
examination. The spinal cord samples of all animals 
in both groups were embedded in paraffin and fixed 
with 10% buffered formalin for 24 hours. Five µm-thick 
serial sections were cut from the paraffin blocks, using a 
microtome and stained with hematoxylin-eosin (H&E) 
and toluidine blue (TB) for routine histopathological 
examinations. Histopathological sections were subjected to 
descriptive analyses, by an experienced Histopathologist, 
blinded to the groups and study design. 
Blood works
In addition, a number of blood samples were accumulated 
by heart puncture at days 3, 7, 21, and 28, postoperatively, 
just before sacrificing of the rats, and total and differential 
White blood cell (WBC) count, and neutrophil/
lymphocyte ratios (N/L ratio) were evaluated. 
Statistical analysis
The mean of the measured parameters (mean ± SEM) 
were compared between the control and experimental 
groups, using an independent t test. Data changes in each 
group were analyzed, using the ANOVA test. P<0.05 was 
regarded as statistically significant. 
Results 
Histopathological assessment and cell counts
Histological changes in both control and experimental 
groups at third day post-operation revealed apparent 
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hemorrhage and severe inflammation at the injured site 
(Figure 1).
Neural tissue sections from the control group in first week 
post-injury showed extensive necrosis with inflammation 
and obvious hemorrhagic area but less than third day post-
operation. Necrotic and degenerated neurons observed at 
the injured site (Figure 2).
Histological features of animals in experimental group in 
first week after surgery indicated degenerated and necrotic 
neurons with moderate hemorrhage and inflammation at 
the lesion site (Figure 3).
During the third week, mild to severe hemorrhage and 
inflammation, accompanied with notable neuronal 
necrosis were observed in the control group (Figure 
4), while considerable reduction in inflammation and 
hemorrhage also with total necrosis of gray matter of cord 
were noticed in the experimental group (Figure 5). 
At 28th day post-injury in the control group, minimal 
hemorrhage, and mild inflammation were noted, while 
neuronal necrosis in both gray and white matter was 
observed (Figure 6). However, in the experimental group, 
the smallest amount of inflammation and hyperemia 
accompanied with little necrotic neuronal zones was 
detected at the lesion site (Figure 7). In sum, descriptive 
data revealed a considerabe decrease in inflammation and 
hemorrhage, during the third and fourth weeks, in the 
experimental group, compared to the control group. 
Leukogram analysis
Mean (±SEM) of the total Wright-Giemsa stained white 
blood cell (tWBC) of the different times, in both groups 
are delineated in Figure 8. There was no significant 
difference between this parameter in day 3 and week 1 of 
the study (P ˃  0.05). Analyzed data revealed a significant 
decrease in tWBC, during the third and fourth weeks, in 
the experimental group, compared to the control group 
(P < 0.05). 
Figures 9 to 11 show neutrophils, lymphocyte, and 
Figure 1. Day 3 of post-operation in both groups; severe hemorrhage 
(arrow) around the lesion; H&E stain (left), TB stain (right); scale bar 
=56 µm
Figure 3. Histological features in the experimental group at first week 
after surgery; moderate inflammation and hemorrhage (arrow) and 
necrosis (arrowhead) around the injured site; H&E stain (left), TB stain 
(right); scale bar= 56 µm.
Figure 4. Histopathological changes in the control group at 3rd week 
after operation; Hemorrhage (arrow) and inflammation accompanied 
with neuronal necrosis (arrowhead) in the defected site; H&E stain 
(left and below), TB stain (right); scale bar= 56 µm.
Figure 5. Histopathological findings in the experimental group at 
3rd week post-surgery; hemorrhage (arrow) and neuronal necrosis 
(arrowhead) in the vicinity of the lesion; H&E stain (both figs.); scale 
bar =56 µm.
Figure 2. Histological structures in the control group at 1st week after 
surgery; Inflammation and obvious hemorrhage (arrow) with neuronal 
necrosis (arrowhead) at the lesion site. H&E stain (left fig.), TB stain 
(right fig.); scale bar= 56 µm
Journal of Herbmed Pharmacology, Volume 7, Number 4, October 2018            http://www.herbmedpharmacol.com276 
Javdani et al
monocyte changes during the different times of the 
current study in the control and experimental groups. 
There were significant differences between mean (±SEM) 
of the neutrophils in week 1 and week 4 of the study 
(P  ˃  0.05). 
The analyzed results revealed a significant reduction 
between the mean (±SEM) of lymphocyte, between the 
control and experimental groups in day 3 and week 4 
after operation. Twenty-eight days after surgery, the mean 
(±SEM) of monocyte showed remarkable differences 
(P = 0.02), between both groups. Evaluation of N/L ratio 
in the 2 groups demonstrates significant difference during 
weeks 1 and 4.
The presented figures delineated alternations of 
inflammatory cells (lymphocytes, neutrophils, and 
Figure 6. Histological findings in the control group at 4th week after 
surgery; Neuronal necrosis (arrowhead) and hemorrhage (arrow) at 
the lesion site; H&E stain (left), TB stain (right); scale bar= 56 µm.
Figure 9. Neutrophils (106/L) changes during the different times in 
both groups; Con.: Control group, Exp.: Experimental group.
Figure 10. Lymphocyte (106/L) changes during the different times in 
both groups. Con.: Control group, Exp.: Experimental group.
Figure 11. Monocyte (106/L) alternations at the different times in 
the control and experimental groups; Con.: Control group, Exp.: 
Experimental group.
Figure 7. Histological findings in the experimental group at 4th week 
after surgery; minimal hyperemia (arrow) and mild inflammation with 
necrotic neurons (arrowhead); H&E stain (left), TB stain (right); scale 
bar= 56 µm.
Figure 8. tWBC (106/L) changes during the various times in both 
groups; tWBC: total White Blood Cell; Con.: Control group, Exp.: 
Experimental group.
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monocytes), at different times, in the control and 
experimental groups. These figures show noticable 
decrease of neutrophils over the 7 days after spinal injury 
(P < 0.05), resulting in an obvious decrease of tWBC due 
to surgery. 
Discussion 
Over the past few years, the extent of herbal extracts 
utilization with neuroprotective activities, such as 
Boswellia species in biological needs have been widened. 
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For that reason, the contemporary study was conducted 
to decrease the inflammation and also to promote 
myelination associated with oral medication of B. serrata 
extract, in the rat suffered from compressive SCI. Twenty-
eight days administration of this extract in the affected 
adult female rats, showed interesting findings that the 
extract could limit secondary complications following 
SCI.
Trauma, as a mechanical damage, compresses the spinal 
cord and disfigures the cord vessels and produces 
hemorrhage at the contusion site, and after a period of 
time induces edema and regional ischemia (22,23). 
Secondary complications will happen after few minutes 
and move forward several weeks following SCI, and 
the correlated events, such as inflammation, gliosis, 
and neuronal degeneration cause severe functional 
abnormalities. Post-traumatic inflammatory environment 
has associated with active microglia and astrocytes, and 
as well penetrated macrophages, which strongly make it 
possible to develop secondary damages. The angiogenic 
reactions and reconstruction of vessels increase secondary 
injuries. Therefore, restriction of secondary injuries leads 
to limiting of neurodegeneration, and subsequently 
functional recovery attains more rapid (22,24). SCI 
induces immune depression syndrome, which is due 
to disturbance of the sympathetic nervous system and 
impairment of the immune system function (25). 
Additionally, general inflammatory responses, because of 
SCI, persuade an increase of inflammatory cells into the 
circulation and secondary tissues, activation of immune 
cells, and pro-inflammatory cytokine secretion, all of 
which intervene with the pathogenesis of various organs 
after SCI (22). Evaluated leukograms in the current 
experiment revealed a significant decrease in total WBCs 
and neutrophils during the third and fourth weeks, in 
the experimental group, compared to the control group. 
Furthermore, histological sections during these weeks 
confirmed notable reduction of inflammation in the 
experimental group in comparison to the control group.
The advantage of N/L ratio is related to anticipation of 
systemic inflammation and stress (26,27). In fact, it is index 
of a disorganized cell-mediated immunity, related to the 
systemic inflammation (28). Our data showed a notable 
decrease of N/L ratio in the experimental and control 
groups that is related to significant increase of neutrophils 
at the day 7. There was no significant difference between 
two groups about this value in various times. 
An interesting point to consider is that the total 
population of WBCs in the current study was significantly 
less in the experimental group, compared to the control 
group at third and fourth weeks of the study which is 
related to the anti-inflammatory effects of B. serrata 
extract. Histopathological evaluation of lesion sites 
confirmed this desirable effect. Similar other studies, our 
data reveal that neutrophils are needed for encouraging 
functional recovery after spinal cord damage. They are 
initial inflammatory cells which appear at the lesion 
site and act by different mechanisms, such as releasing 
angiogenic factors, to induce inflammation-mediated 
tissue remodeling (29,30).
We did not find any studies that investigate effects of 
B. serrata extract on the neuronal cells in traumatic 
SCI. A few available studies just evaluated effects of this 
medicine herb on the brain. Resins of Boswellia species 
act as a natural anti-inflammatory product that has been 
administrated in some centuries (9). 
Several found compounds of Boswellia have effects on the 
immune system in different routes. Boswellic acids, beta-
boswellic acid (BA), 3-acetyl-beta-boswellic acid (ABA), 
11-keto-boswellic acid (KBA) and 3-acetyl-11-keto-beta-
boswellic (AKBA), are named as the major ingredients 
of B. serrata (31). AKBA, as a potent component of 
extract of B. serrata, move across the blood brain barrier 
(32) and is able to inspire its anti-inflammatory effects. 
Boswellic acids (AKABA) inhibit 5-lipoxygenase enzyme 
so suppress leukotriene biosynthesis. It has been revealed 
that boswellic acid decreases some interleukins (1, 2, 4, 
6, 10, 12) and IFNᵞ, induces down regulation of Tumor 
necrosis factor (TNFɑ), and puts down WBC migration. 
Also, B. serrata suppresses mast cell degranulation and 
induction of monocytes and macrophages and inhibits 
pathways of complement directly or indirectly (33). 
It has been reported that boswellic acids through 
activating protein kinase-C, is effective in learning and 
memory storage and cause synaptic plasticity in the 
hippocampus (34,35). Another identified constituent in 
Boswellia resin is incensole-acetate, which shows anti-
inflammatory activities on the central nervous system 
(CNS) and has been shown antianxiety and in addition 
anti-depression impacts. Previous studies have revealed 
that incensole-acetate holds back degenerative changes 
in the hippocampus by increase of calcium influx and 
releasing of calcium dependent-neurotransmitters 
in the brain (13,14,36). So, it seemed that Boswellia 
serrata extract by inhibition of different enzymes of the 
arachidonic acid cascade including lipoxygenases and 
cyclooxygenases potentially are able to control secondary 
injuries of compressed spinal cord. Therefore, evaluation 
of these enzymes in the future is recommended.
Conclusion
Examined histologic sections and analyzed systemic WBC 
alternations in the experimental group of the present study 
confirmed anti-inflammatory effects of oral consumption 
of Boswellia serrata extract in the rats suffered traumatic 
spinal cord damage.
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